Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 2Myeloid 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1

Conditions

Anemia 2Uterine Cervical Neoplasms 1Radiation Injuries 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

fludarabine phosphate 58Cyclophosphamide 54Epoetin Alfa 43Cyclosporine 43Busulfan 43Peripheral Blood Stem Cell Transplantation 39Mycophenolic Acid 34Darbepoetin alfa 33Antilymphocyte Serum 31Whole-Body Irradiation 30Cytarabine 30Filgrastim 29Methotrexate 26Tacrolimus 25Radiotherapy 25Melphalan 24fludarabine 21Methylprednisolone 17Cord Blood Stem Cell Transplantation 17Etoposide 14Granulocyte Colony-Stimulating Factor 13Daunorubicin 13Rivaroxaban 12apixaban 11Thiotepa 11sargramostim 10epoetin beta 10Dalteparin 10eltrombopag 9Alemtuzumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Erythropoietin × Classical hematology × Clear all
NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT02767765 2017-04-04

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Hoffmann-La Roche

Phase 3 Completed
61 enrolled 11 charts
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡